CytomX Therapeutics Announces the Planned Retirement of Chief Scientific Officer, W. Michael Kavanaugh, M.D.


Marcia P. Belvin, Ph.D., Promoted to Senior Vice President, Head of Research

Continued here:
CytomX Therapeutics Announces the Planned Retirement of Chief Scientific Officer, W. Michael Kavanaugh, M.D.

Related Posts